Since MASLD induces a vicious interorgan cross-talk between multiple metabolic organs such as muscle and heart, Wee1-AS could be a valuable therapeutic target for MASLD treatment. Here, WEE1 is linked to metabolic dysfunction-associated steatotic liver disease.